Concepedia

Vadim Le Joncour

VL

Statistics

Publications

24

Citations

766

H-Index

16

Active since

2010

Affiliations

University of Helsinki(Current)

Inserm

Université de Rouen Normandie

Helsinki University Hospital

Différenciation et Communication Neuronale et Neuroendocrine

Vadim Le Joncour is an author at University of Helsinki specializing in medicine, oncology, and pharmacology.

Publications per year

2010–2025

24

Publications

24

A Novel Anti-HER2 Antibody–Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine

Vadim Le Joncour, Ana Martins, Maija Puhka et al. · Molecular Cancer Therapeutics · 2019 · 85 citations · Full text

Medicine, Oncology, Pharmacology +17

ARX788, a novel anti-HER2 antibody-drug conjugate, shows anti-tumor effects in preclinical models of trastuzumab emtansine-resistant HER2-positive breast cancer and gastric cancer

Márk Barok, Vadim Le Joncour, Ana Martins et al. · Cancer Letters · 2020 · 82 citations · Full text

Medicine, Oncology, Pharmacology +16

Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression

Johanna Eriksson, Vadim Le Joncour, Pirjo Nummela et al. · Oncotarget · 2016 · 71 citations · Full text

Medicine, Cancer Biology, Oncology +17

Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization

Vadim Le Joncour, Pauliina Filppu, Maija Hyvönen et al. · EMBO Molecular Medicine · 2019 · 59 citations · Full text

Medicine, Cell Biology, Oncology +17

CD109-GP130 interaction drives glioblastoma stem cell plasticity and chemoresistance through STAT3 activity

Pauliina Filppu, Jayendrakishore Tanjore Ramanathan, Kirsi J. Granberg et al. · JCI Insight · 2021 · 58 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 24